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Abstract—Alcoholism has always been a major public health 
concern in Taiwan, especially in the aboriginal communities. 
DNA methylation has recently been found to be associated with 
alcoholism. Since 1986, we have been following up on the mental 
health conditions of four major aboriginal peoples of Taiwan. In 
the current study, we attempted to profile the effect of chronic 
alcohol exposure on the epigenome. Clinical interviews were 
performed on 993 aboriginal people at phase 1 (1986), and 
followed up through phase 2 (1990-1992), and phase 3 (2003-
2009) with DNA preparations at phases 2 and 3. Selected 
individuals for the present study included males from the phase 1 
normal cohort who remained normal at phase 2 and became 
dependent on alcohol by phase 3 (n=10) and control subjects that 
have not had any drinking problems throughout the study 
(n=10). We assessed changes in DNA methylation in the blood 
collected at phases 2 and 3. Preliminary data show that 201 and 
254 genes contain sites that are differentially methylated between 
the two collection time points in the control and case subjects, 
respectively. Among the list of genes differentially methylated in 
the case group, the methylation levels of 6 genes were found to 
correlate with alcohol consumption. These include genes involved 
in neurogenesis (NPDC1) and inflammation (HERC5) as well as 
alcoholism-associated genes ADCY9, CKM, and PHOX2A. Our 
study identified genes that are associated with chronic alcohol 
consumption at the epigenetic level. The results offer a 
comprehensive epigenomic map that helps enhance our 
understanding of alcohol-induced damages. 
Keywords- alcoholism; epigenetic profiling; DNA methylation; 
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I.  INTRODUCTION  
Multiple genetic factors determine an individual’s 
predisposition to alcohol use disorder (AUD) [1-3]. 
Approximately 40 to 60% of the variance in the development 
of alcohol dependence is attributable to the genotype [4, 5]. As 
dependence develops only following repeated use, the 
neurobiological changes that arise in response to repeated 
alcohol exposure are the key factors interplaying between the 
genotype and the environment [6].  
Alcohol exposure is known to cause aberrant DNA 
methylation [7-9], which is the best understood epigenetic 
modification of gene expression. The severity of epigenetic 
changes can be aggravated by alcohol consumption [9]. 
Understanding the epigenetic process of chronic alcohol use 
may represent a potential therapeutic target for compulsive 
drinking. 
Emerging evidence supports the involvement of DNA 
methylation changes in alcoholism. For example, alpha 
synuclein, a gene associated with dopaminergic 
neurotransmission, showed promoter DNA hypermethylation 
in the peripheral mononuclear cells of alcohol dependent 
patients [10]. Altered DNA methylation has been found in the 
promoters of the atrial natriuretic peptide, vasopressin, and N-
methyl-D-aspartate 2b receptor subtype genes in patients 
undergoing alcohol withdrawal [11, 12]. Hypermethylation of 
the dopamine transporter gene has been associated with alcohol 
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dependence [13]. Methylation of the CpG sites in the promoter 
region of the polypeptide pro-opiomelanocortin is different 
between alcohol-dependent and healthy controls and linked to 
craving [14]. These studies indicate that changes in DNA 
methylation may contribute to the complex spectrum of AUD. 
A genome-wide approach has the potential to uncover the 
various epigenetic signatures of alcoholism. 
In this study, we assessed DNA methylation changes of 
long-term alcohol consumption among subjects from a 
longitudinal study of AUD in the Taiwan Aboriginal Study 
Project (TASP) [15]. TASP began in 1986 (N=993) with four 
major Taiwanese aboriginal groups (Ami, Atayal, Paiwan, and 
Bunun). In the phase 1 cross-sectional survey (1986-88), high 
lifetime prevalence rates of DSM-III-R AUD were found 
among the four groups, ranging from 44.5% to 54.5% [16]. In 
the phase 2 follow-up conducted four years later (1990-92), the 
age-standardized annual incidence rates of AUD among the 
four groups were found to range from 2.8 to 4.9% [17]. A 
phase 3 16-year follow-up was conducted in 2003-2009. The 
blood samples collected at phases 2 and 3 with 12 years in 
between presented a great opportunity to examine the effect of 
alcohol drinking on DNA methylation among incidence cases 
of AUD during the period. Here, we report a genome-wide 
profiling of DNA methylation changes associated with chronic 
alcohol consumption, providing an epigenomic picture that 
help enhance our understanding of alcohol-induced damages. 
II. METHODS AND MATERIALS 
A. Participants 
All procedures were reviewed and approved by the 
Institutional Review Board of Academia Sinica, Taiwan, and 
written informed consents were obtained from all participants. 
For those who had reduced ability to consent, the carers or 
guardians gave written informed consent on behalf of these 
participants. Our analysis was based on a subset of participants. 
Because existing evidence suggests that DNA methylation may 
be gender specific [18, 19], this study only focused on male 
cohort subjects as a preliminary investigation into the 
association between DNA methylation and alcohol drinking.  
Several criteria were considered for the selection of cases. 
Since DNA preparation was performed at phases 2 and 3, study 
subjects must have DNA samples available from both phases. 
The amount and the quality of these samples must meet the 
requirements for array analysis as well. Also, to study the 
effect of alcohol on methylation patterns, we chose AUD cases 
with no lifetime drinking problem at phase 2, but had 
developed AUD after phase 2 and were diagnosed with DSM-
IV alcohol dependence at phase 3. Moreover, these subjects 
must have been heavy drinkers (≥ 80g of alcohol intake/day) 
at phase 3 when their blood samples were collected. All 
subjects from the male cohort fulfilling these criteria have been 
included (N=10). Every case was matched in age (±3 years) 
with one male control who had never been found to have 
lifetime DSM-IV alcohol dependence throughout the three 
waves of investigations. 
B. Methylation analysis 
For each individual, 10 ml of blood was drawn at phases 2 
and 3. Blood samples were collected into BD Vacutainer® 
SST™ blood collection tubes (Franklin Lakes, NJ, USA).  
DNA extraction was performed using the Gentra Puregene 
Blood Kit (QIAGEN, Valencia, CA, USA) according to the 
manufacturer’s instructions. DNA quality and quantity were 
determined on a NanoDrop ND-1000 spectrophotometer 
(NanoDrop Techonologies, Wilmington, DE, USA). DNA 
integrity was evaluated by agarose gel electrophoresis. 500 ng 
of each sample underwent bisulfite conversion using the EZ 
DNA methylation kit from Zymo Research (Orange, CA, 
USA) following the manufacturer’s protocol with 
modifications recommended by Illumina (San Diego, CA, 
USA). To confirm that bisulfite conversion was successful, 
quality control PCR reactions were performed for each sample 
using the primers and protocol described by Thirlwell et al. 
(2010) [20]. Bisulfite converted DNA samples were then 
subjected to methylation profiling on the Infinium® 
HumanMethylation27 BeadChips (Illumina Inc., San Diego, 
CA, USA) according to Illumina’s instructions at Genetech 
Biotech in Taipei, Taiwan. Each locus was interrogated by a 
specific probe linked to a methylated (M) and unmethylated 
(U) bead type. Fluorescent intensities of the M and U beads 
were used to calculate the methylation status of a specific CpG 
site, following the formula: ß=M/((M+U)+100). 
C. Statistical analysis 
Comparisons of variables such as age, alcohol 
consumption, smoking and betel nut use were performed using 
the Mann-Whitney test in SPSS v18.0 (Somers, NY, USA). For 
methylation comparison, data were background normalized in 
Illumina’s BeadStudio (San Diego, CA, USA) and exported for 
additional analysis using GeneSpring® (Agilent Technologies, 
Santa Clara, CA, USA). Our analysis was based on genes 
corresponding to CpG sites (or probes) that were methylated or 
unmethylated. Average beta values for the CpG sites in the 
case and control groups were calculated. In our data, there were 
genes with two or more sites showing similar results. These 
duplicate records were removed so that the same genes were 
not counted twice.   
Differential methylation between phases 2 and 3 in the case 
and control was analyzed using Wilcoxon paired sample test. 
Differential methylation at a particular CpG site was 
considered to be significant if p<0.01. Neither the case nor the 
control group was genotyped for the CpG sites. Since it was 
possible that genotype may affect methylation, we limited our 
analysis to identifying methylation differences that occurred 
within each individual from phase 2 to phase 3, and not 
between the case and control groups. However, significantly 
differentially methylated genes (or CpG sites) in the control 
group were used to identify potential aging-related changes in 
the case group. The remaining differentially methylated genes 
were then analyzed for correlation with alcohol consumption 
using Spearman’s correlation test. 
D. Bioinformatics analysis 
We used MetaCore (GeneGo, St. Joseph, MI) to analyze 
significantly differentially methylated genes. Gene set 
enrichment analysis was performed to evaluate the most 
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important biological processes, molecular functions, and 
networks. For a network of a given size, MetaCore can be used 
to calculate statistical significance based on the probability of 
the network’s assembly from a random set of nodes (genes) 
and the same size as the input list (P value). 
III. RESULTS 
The case and control groups appeared to be similar in the 
distribution of age, education, mental disorders, and average 
alcohol consumption at phases 1 and 2 (Table 1). Average 
monthly alcohol consumption at phase 3 was significantly 
much higher in the case than in the control group. The use of 
betel nut and cigarette was only enquired at phase 3. Only 
cigarette smoking showed a significant difference between the 
case and control group at phase 3 (Table 1: Mann Whitney 
U=26.0, p=0.055 for betel nut; Mann Whitney U=26.5, 
p=0.045 for cigarette smoking). As we only have detailed 
information regarding alcohol consumption in all phases of the 
study and the average amount of cigarette consumed in both 
groups appeared to be small, we speculated that alcohol 
contributed strongly to the differences between the case and 
control group. Hence, our analysis was focused on the 
relationship between alcohol and DNA methylation.  
We determined the number of shared and group-specific 
differentially methylated genes in the normal and alcohol-
dependent individuals for each phase (Fig. 1). Among the 
27,578 CpG sites interrogated in this study, 252 (68 up- and 
184 down-regulated genes) and 200 (149 up- and 51 down-
regulated genes) were found to be in the control and case 
group, respectively. The two groups shared three differentially 
methylated genes. Interestingly, there appeared to be genome-
wide down-regulation of methylation in the control group. Yet, 
in the case group, there seemed to be global hypermethylation.   
The differentially methylated genes identified from our 
study have diverse molecular roles, including signal 
transduction, intracellular trafficking, stress and immune 
responses, structural maintenance, as well as regulation of 
metabolism and transcription.  
We performed bioinformatics analysis using Metacore to 
identify the relevant biological pathways that are important in 
the case and control groups (Fig. 2). The genes that were 
differentially methylated in the control group seemed to be 
more enriched in the categories under visual perception,  
 
TABLE I. SOCIO-DEMOGRAPHIC CHARACTERISTICS, USE OF CIGARETTE AND 
BETEL NUT, AND PSYCHIATRIC DIAGNOSES IN THE CASE AND CONTROL GROUPS 
OF ALCOHOL USE DISORDER AT THREE PHASES DURING THE FOLLOW-UP. 
 Controls  
N=10 
Cases 
N=10 
Non-parametric 
statistics (p-
value) 
Age 40 + 2 39 + 2 0.36 
Education (years) 11 + 2 10 + 3 0.37 
Phase 1 average alcohol 
consumption 
(units/month) 
4.3 + 1.9 15.8 + 6.8 0.30 
Phase 2 average alcohol 
consumption 
(units/month) 
19.3 + 12.0 31.1 + 9.47 0.40 
Phase 3 average alcohol 
consumption 
(units/month) 
39.5 + 1.44 589 + 122 0.00 
Phase 3 betel nut use 
(number/month) 
2 + 1 5 + 1 0.055 
Phase 3 cigarette smoking 
(number/month) 
3 + 1 6 + 1 0.045 
Depressive disorders, N 2 4 0.08 
Anxiety disorders, N 2 3 1.00 
Adjustment disorder, N 1 0 0.748 
One unit of alcohol is defined as 12 grams of alcohol. Anxiety disorders include generalized anxiety 
disorder, panic disorder, posttraumatic disorder, and anxiety disorder, NOS. Depressive disorders 
include major depressive disorder and dysthymic disorder. 
TABLE II. CORRELATION OF DIFFERENTIALLY METHYLATED GENES WITH 
AVERAGE MONTHLY ALCOHOL CONSUMPTION IN CASE SUBJECTS OVER THE 12 
YEARS BETWEEN PHASES 2 AND 3. 
 Gene ID Product Correlation
ADCY9 115 adenylate cyclase type 9 0.60 
TMEM45B 120224 transmembrane protein 45B 0.59 
PHOX2A 401 paired-like homeobox 2a 0.70 
HERC5 51191 HECT domain and RLD 5 0.66 
CKM 1158 muscle creatine kinase -0.56 
NPDC1 56654 neural proliferation, 
differentiation, and control, 1 
-0.67 
Pearson correlation test, p<0.01 
immune response, cell adhesion and differentiation. In 
contrast, those in the alcoholic group appeared to be involved 
in functional pathways responsible for molecular and cellular 
structural maintenance, lipid metabolism, glucocorticoid 
receptor signaling, apoptosis and oxidative stress, as well as 
atherosclerosis associated gene regulation. 
We constructed a gene-gene interaction network and 
correlation analysis of the differentially methylated genes to 
identify changes in methylation that may be associated with 
alcohol consumption. The interaction network identified the 
possible dynamics underlying alcohol-induced damages (Fig. 
3). Correlation analysis also showed that several genes 
involved in cellular stress pathways were associated with 
average monthly alcohol consumption over the 12 years 
between phase 2 and phase 3 (Table 2).  
IV. DISCUSSION 
Based on a longitudinal follow-up study of AUD in 
Taiwanese aborigines, our findings reveal genome-wide 
hypermethylation associated with alcohol dependence, 
consistent with other studies [10, 12, 13, 21]. Further, we have 
identified several specific epigenetic signatures associated with 
chronic alcohol consumption. Compared to the control group,  
most of the differentially methylated genes in the case group, 
are involved in lipid metabolism and atherosclerosis regulation, 
 
Figure 1. Number of genes differentially methylated in the control and case
group. Red and blue represent control- and case-specific differentially
methylated genes, respectively. Purple indicates genes that are differentially
methylated in both cases and controls. 
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cellular and molecular structural integrity, and cellular stress 
pathways. Our results are in line with the observations that 
chronic alcohol exposure leads to alterations in membrane 
structures [22], as well as actin and microtubule organization 
[23]. Several studies have linked heavy alcohol consumption 
with a higher risk of atherosclerosis and/or fatty liver [24]. The 
present finding implicates the possible epigenetic mechanisms 
underlying chronic alcohol drinking and the development of 
physical disorders. 
Our gene network analysis indicates that the differentially 
methylated genes in the alcoholic individuals are involved in 
complex interactions with each other (Fig. 3). Most of these 
associations are linked through two alcoholism-related genes: 
androgen receptor (AR) and arginine vasopressin protein 
(AVP). AR is known to have a modulating effect on craving 
during withdrawal in men [25], whereas AVP is associated 
with alcohol tolerance [26]. Connected to the AR and AVP are 
genes involved in aldehyde detoxification (ALDH1A3) [27], 
regulation of circadian clock (PROK2) [28], maintenance of 
cell adhesion (MADCAM1) [29], as well as the development 
of various types of cancer, including MYBL2 [30], CRYAB 
[31], CDKN2B [32], etc. The potential interactions among 
these differentially methylated genes suggest that the effect of 
alcohol on DNA methylation is complex. Alcohol-induced 
changes in methylation may modulate the susceptibility to 
cancer, affect aldehyde metabolism, alter cellular physiology, 
and moreover, regulated behavior. 
Some of the differentially methylated genes in the case 
group are related to the various characteristics of AUD. For 
instance, AR is a craving mediator [25]. Creatine kinase (brain: 
CKB or muscle: CKM) has been associated with alcohol 
dependence, withdrawal and delirium tremens [33]. Our results 
show that methylation of the CKM gene also appears to be 
negatively correlated with alcohol consumption. The 
tachykinin receptor 1 genotypes have been implicated in 
craving and severity of alcohol dependence. Moreover, the 
level of AVP is known to fluctuate with alcohol consumption, 
modulating craving, tolerance and alcohol-induced memory 
impairment [12, 34]. Our observation that these genes are 
differentially methylated in the alcoholic group and potentially 
interacting with each other indicates that DNA methylation 
may represent a possible mechanism underlying AUD. 
Most of the differentially methylated genes in the case 
group are associated with lipid metabolism and atherosclerosis 
regulation, cellular and molecular structural integrity, and cell 
stress pathways. These biological processes are particularly 
sensitive to alcohol-induced damages. Our results are in line 
with the observations that chronic alcohol exposure leads to 
genome-wide hypermethylation, leading to alterations in 
membrane structures [22], actin and microtubule organization 
[23]. Several studies have also linked heavy alcohol 
consumption with a higher risk of atherosclerosis and/or fatty 
liver [24].  
Correlation analysis showed that several genes appear to be 
associated with the level of alcohol consumption. For example, 
adenylate cyclase type 9 (ADCY9) belongs to a family of 
transmembrane proteins involved in learning and memory, 
synaptic plasticity, and neurodegeneration, in addition to 
having been implicated in the development of addiction and 
mood disorders [35, 36]. Several members of the adenylate 
cyclase family are ethanol responsive [37]. This is consistent 
with our observation that chronic alcohol consumption appears 
to be associated with increased methylation of the ADCY9 
gene. In addition, paired mesoderm homeobox protein 2A, 
PHOX2A, is a transcription regulator of the alpha 3 nicotinic 
acetylcholine receptor subunit gene [38], whose overexpression 
has been shown to reduce alcohol intake in mice [39]. It seems 
that the nicotinic acetylcholine receptor may modulate alcohol 
drinking behavior through PHOX2A. That methylation of 
PHOX2A appears to be positively correlated with the amount 
of alcohol consumption offers an additional evidence for the 
association between PHOX2A and alcohol dependence.  
Some of the genes correlated with chronic alcohol 
consumption have been implicated in cell damage and 
inflammatory response. For example, methylation of the HECT 
and RLD domain containing E3 ubiquitin protein ligase 5 
(HERC5) is a regulator of inflammatory response [40]. 
Increased methylation of HERC5 after chronic alcohol 
 
Figure 2. Gene set enrichment analysis of differentially methylated genes in the control and case group. 
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exposure suggests that alcohol may attenuate HERC5’s ability 
to maintain a proper inflammatory response. NPDC1 (neural 
proliferation, differentiation, and control, 1) is a neural factor 
controlling neural cell proliferation and differentiation [41]. 
Alcohol use disorder can result in alcohol-related brain damage, 
but the exact mechanism of this process is not well understood. 
Given NPDC1’s role in neurogenesis and its de-methylation 
with respect to chronic alcohol consumption, it is possible that 
there exists a protective mechanism to compensate alcohol’s 
inhibiting effect on cell proliferation. 
Our results bear relevant biological significance in the 
context of chronic alcohol exposure and alcohol-induced 
damages, but several limitations underlie our study. First, our 
findings, though based on a small sample size of Taiwanese 
aboriginal males, are yet preliminary. It is likely that we might 
have identified male-specific epigenetic markers unique to 
Taiwanese aborigines or overlooked genes of moderate effect. 
Second, our analysis may not fully reflect the changes in gene 
expression and further confirmation at the RNA level is 
required. Third, our epigenetic profiling in the blood may not 
directly represent the situations in other tissues. Finally, the 
lifetime frequencies and amount of cigarette smoking and betel 
nut use were assessed at phase 3 only. Although the average 
amount of cigarettes and betel nuts consumed by the study 
subjects appeared to be low in both cases and controls, we 
could not entirely eliminate the possibility that cigarette and 
betel nut may also modulate DNA methylation. 
Collectively, our study identified genes associated with 
chronic alcohol consumption at the epigenetic level. Though 
various questions remain unanswered, by presenting a 
comprehensive epigenomic map of a longitudinal follow-up 
study on alcohol use disorder, we have provided support for the 
emerging notion that epigenetics plays a role in alcoholism 
etiology and facilitate the effort of research in this area. 
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